샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794690

세계의 신부전 치료 시장

Renal Failure Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 282 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신부전 치료 세계 시장은 2030년까지 1,822억 달러에 달할 전망

2024년에 1,170억 달러로 추정되는 신부전 치료 세계 시장은 2024-2030년 분석 기간 동안 CAGR 7.7%로 성장하여 2030년에는 1,822억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 투석 치료는 CAGR 9.1%를 기록하며 분석 기간 종료시에는 893억 달러에 달할 것으로 예상됩니다. 신장 이식 치료 부문의 성장률은 분석 기간 동안 CAGR 5.4%로 추정됩니다.

미국 시장은 319억 달러로 추정, 중국은 CAGR 12.2%로 성장 예측

미국의 신부전 치료 시장은 2024년에 319억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 392억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.7%와 7.4%로 예측됩니다. 유럽에서는 독일이 CAGR 5.1%로 성장할 것으로 예측됩니다.

세계의 신부전 치료 시장 - 주요 동향과 촉진요인 정리

신부전증 정세는 어떻게 통합의료와 맞춤의료로 전환되고 있는가?

신부전, 특히 말기 신부전(ESRD)은 만성 신장병(CKD)의 마지막 단계이며, 신장이 더 이상 필수적인 여과 및 조절 기능을 수행할 수 없게 됩니다. ESRD 환자는 투석이나 신장이식을 포함한 신대체요법(RRT)이 필요합니다. 당뇨병, 고혈압과 같은 만성질환으로 인한 ESRD의 전 세계 유병률 증가는 의료시스템에 급성기 및 장기적인 관리 전략의 최적화에 대한 큰 압박을 가하고 있습니다. 이러한 변화는 조기 진단, 치료 조정, 치료 후 지원을 강화하기 위해 신장 치료의 틀을 재평가하도록 촉구하고 있습니다.

스크리닝, 약리학적 관리, 식이 상담, 적시 투석 도입 등을 통합한 신장병 치료 모델이 점점 더 활발해지고 있습니다. 나트륨-포도당 공수송체-2(SGLT2) 억제제와 같은 조기 개입은 신부전 진행을 지연시키고, 단백뇨를 감소시키며, 심혈관 위험을 낮추는 데 효과적임이 입증되고 있습니다. 이 약물들은 현재 CKD 치료 초기에 처방되어 향후 투석 의존도를 낮추기 위해 처방되고 있습니다. 또한, 모바일 헬스 플랫폼과 원격 모니터링 도구는 특히 재택 투석 및 이식 전 평가에 대한 환자 참여를 촉진하여 결과와 비용 효율성을 개선하고 있습니다.

복잡한 환자 요구에 대응하기 위해 진화하고 있는 치료법은 무엇인가?

투석은 여전히 신부전 관리의 핵심이며, 혈액투석(HD)과 복막투석(PD)으로 나뉩니다. 혈액투석은 투석 센터에서 이루어지다가 최근에는 가정에서도 이루어지고 있으며, 투석기, 웨어러블 기술, 첨단 여과막의 혁신으로 뒷받침되고 있습니다. 대류 투석과 확산 투석을 결합한 온라인 혈액투석 여과(HDF)는 독소 제거를 개선하기 위해 채택되고 있습니다. 재택 혈액투석 시스템은 현재 컴팩트하고 휴대가 가능하며, 연결이 가능하여 합병증을 줄이고 삶의 질을 향상시키는 개인별 맞춤 치료가 가능해졌습니다.

복막투석도 비용 효율성과 환자의 자율성으로 인해 특히 아시아태평양과 라틴아메리카에서 부활하고 있습니다. 원격 데이터 전송과 스마트한 수액 관리 기능을 갖춘 자동 복막투석기는 보다 안전하고 효율적인 셀프 케어를 가능하게 합니다. 신장 이식은 여전히 가장 확실한 치료법이지만 장기 부족, 면역억제 합병증, 자격 제한으로 인해 이식에 대한 접근성이 제한되어 있습니다. 이식 풀을 확대하기 위해 쌍신장 교환, 탈감작 프로토콜, 기증자 장기의 정상 온열 기계 관류 등의 방안이 검토되고 있습니다. 면역요법이나 바이오 인공신장과 같은 재생 접근법은 전임상 단계에 있으며, ESRD 관리에 장기적인 가능성을 제공하고 있습니다.

시장의 우선순위를 바꾸고 있는 지역 시스템과 환자 집단은?

미국, 일본, 서유럽과 같은 고소득 국가들은 성숙한 투석 및 이식 시스템을 보유하고 있지만, 비용 억제와 ESRD 인구의 고령화라는 과제에 직면해 있습니다. 이들 지역에서는 투석의 재택화, 원격의료 이용 확대, 예방적 신장내과 서비스 도입에 힘을 쏟고 있습니다. 미국 메디케어의 ESRD 프로그램은 조기 의뢰와 치료 방법의 다양화에 대한 보상으로 일괄 지불 및 품질 기반 상환으로 계속 진화하고 있습니다. 유럽에서는 웨어러블 투석 시스템에 대한 투자와 정책 개혁을 통한 기증 장기 활용 확대가 진행되고 있습니다.

신흥국은 CKD 유병률 상승과 신장내과 인프라에 대한 정부 투자로 인해 시장 확대의 초점이 되고 있습니다. 중국의 국가 투석 프로그램, 인도의 Pradhan Mantri National Dialysis Program, 라틴아메리카의 PPP 모델은 모두 치료 접근성을 확대하고 있습니다. 그러나 경제적 여유는 여전히 장벽으로 작용하고 있으며, 저가형 투석기, 재사용 가능한 소모품, 제네릭 면역억제제에 대한 수요를 촉진하고 있습니다. 젊은 연령대의 ESRD 환자들은 선천성 또는 자가면역질환으로 인해 영향을 받는 경우가 많아 평생 동안 양질의 신장 관리가 필요한 환자군입니다. 이러한 환자들의 존재는 비용, 혁신, 공평한 접근의 균형을 맞추는 시스템에 대한 압력을 가중시키고 있습니다.

신부전 치료 시장의 성장을 촉진하는 요인은 무엇인가?

신부전 치료 시장의 성장은 ESRD 유병률 증가, 투석 인프라 확대, 이식률 증가, 초기 CKD 치료법의 혁신에 의해 이루어질 것입니다. CKD는 많은 환자에서 진단되지 않은 채로 진행되기 때문에 의료 시스템은 신부전을 늦추거나 관리하기 위한 선별 프로그램 및 만성 치료 경로에 투자하고 있습니다. 재택 투석 솔루션, AI를 활용한 투석 계획 도구, 웨어러블 투석기기는 투석 치료를 보다 친숙하고 환자 친화적으로 만들고 있습니다.

이식은 장기 보존 기술, 생체 기증자 옹호, 이식 후 관리에 대한 정부 보조금에 의해 촉진되고 있습니다. 신장 보호제, 디지털 순응도 플랫폼, 하이브리드 치료 센터의 개발로 CKD-ESRD의 연속적인 치료의 질이 향상되고 있습니다. 세계 자금 조달 이니셔티브, PPP 모델, 의료 기술 기업과 제약 기업의 전략적 제휴는 의료 서비스가 부족한 지역에 대한 시장 진입을 가능하게 하고 있습니다. 이러한 힘들이 결합되어 신부전 치료 시장은 정밀성, 접근성, 통합된 만성질환 관리로 정의되는 미래를 향해 나아가고 있습니다.

부문

치료(투석 치료, 신장 이식 치료, 약물요법 치료, 기타 치료), 최종사용자(병원 최종사용자, 전문 클리닉 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • AbbVie Inc.
  • Akebia Therapeutics, Inc.
  • Amgen Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company(BD)
  • Calliditas Therapeutics AB
  • DaVita Inc.
  • Dialysis Clinic, Inc.(DCI)
  • Fresenius Medical Care AG & Co. KGaA
  • GSK plc
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • NIPRO Corporation
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Toray Industries, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Renal Failure Treatment Market to Reach US$182.2 Billion by 2030

The global market for Renal Failure Treatment estimated at US$117.0 Billion in the year 2024, is expected to reach US$182.2 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Dialysis Treatment, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$89.3 Billion by the end of the analysis period. Growth in the Kidney Transplantation Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Billion While China is Forecast to Grow at 12.2% CAGR

The Renal Failure Treatment market in the U.S. is estimated at US$31.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$39.2 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Renal Failure Treatment Market - Key Trends & Drivers Summarized

How Is the Renal Failure Landscape Shifting Toward Integrated and Personalized Care?

Renal failure, particularly end-stage renal disease (ESRD), represents the final progression of chronic kidney disease (CKD), where the kidneys can no longer perform essential filtration and regulatory functions. Patients with ESRD require renal replacement therapy (RRT), which includes dialysis or kidney transplantation. The increasing global incidence of ESRD-driven by chronic diseases such as diabetes and hypertension-is placing immense pressure on healthcare systems to optimize both acute and long-term management strategies. This shift is prompting a re-evaluation of renal care frameworks to enhance early diagnosis, care coordination, and post-treatment support.

Integrated nephrology care models that unify screening, pharmacologic management, dietary counseling, and timely dialysis initiation are gaining momentum. Early-stage interventions such as sodium-glucose cotransporter-2 (SGLT2) inhibitors are proving effective in delaying progression to renal failure, reducing proteinuria, and lowering cardiovascular risks. These agents are now being prescribed earlier in the CKD treatment journey to reduce future dialysis dependency. Additionally, mobile health platforms and remote monitoring tools are facilitating patient engagement, particularly for home-based dialysis or pre-transplant evaluations, improving outcomes and cost-efficiency.

Which Treatment Modalities Are Evolving to Meet Complex Patient Needs?

Dialysis remains the cornerstone of renal failure management, divided into hemodialysis (HD) and peritoneal dialysis (PD). Hemodialysis, performed at centers or increasingly in homes, is supported by innovations in dialysis machines, wearable technologies, and advanced filtration membranes. On-line hemodiafiltration (HDF), which combines convective and diffusive clearance, is gaining adoption for improved toxin removal. Home hemodialysis systems are now compact, portable, and connected, enabling personalized care with fewer complications and better quality of life.

Peritoneal dialysis is also witnessing a resurgence, especially in Asia-Pacific and Latin America, due to its cost-effectiveness and patient autonomy. Automated PD machines with remote data transmission and smart fluid management are enabling safer and more efficient self-care. Kidney transplantation remains the most definitive treatment, but organ shortages, immunosuppressive complications, and eligibility limitations restrict access. To expand the transplant pool, initiatives like paired kidney exchange, desensitization protocols, and normothermic machine perfusion for donor organs are being explored. Immunotherapy and regenerative approaches such as bioartificial kidneys are in preclinical stages, offering long-term potential for ESRD management.

Which Regional Systems and Patient Populations Are Reshaping Market Priorities?

High-income countries such as the U.S., Japan, and Western Europe have mature dialysis and transplant systems, but face challenges in cost containment and aging ESRD populations. These regions are focusing on shifting dialysis to the home setting, increasing the use of telehealth, and incorporating preventive nephrology services. The U.S. Medicare ESRD program continues to evolve with bundled payments and quality-based reimbursement that reward early referral and modality diversification. Europe is investing in wearable dialysis systems and expanding donor organ utilization through policy reforms.

Emerging economies are becoming focal points for market expansion due to rising CKD incidence and government investments in nephrology infrastructure. China’s national dialysis program, India’s Pradhan Mantri National Dialysis Program, and Latin America’s PPP models are all expanding treatment access. However, affordability remains a barrier, spurring demand for low-cost dialysis machines, reusable consumables, and generic immunosuppressants. Younger ESRD patients, often affected by congenital or autoimmune causes, represent a distinct subpopulation requiring lifelong, high-quality renal care. Their presence is increasing pressure on systems to balance cost, innovation, and equitable access.

What Factors Are Driving the Growth of the Renal Failure Treatment Market?

The growth in the renal failure treatment market is driven by the rising prevalence of ESRD, expansion of dialysis infrastructure, increasing transplantation rates, and innovation in early-stage CKD therapies. As CKD continues to advance undiagnosed in many patients, health systems are investing in screening programs and chronic care pathways to delay or manage renal failure. Home dialysis solutions, AI-powered dialysis planning tools, and wearable dialysis devices are making therapy more accessible and patient-friendly.

Transplantation is receiving a boost from organ preservation technologies, living donor advocacy, and government subsidies for post-transplant care. The development of nephroprotective agents, digital adherence platforms, and hybrid treatment centers is improving care quality across the CKD-ESRD continuum. Global funding initiatives, PPP models, and strategic alliances between medtech and pharma firms are enabling market entry into underserved regions. Together, these forces are propelling the renal failure treatment market toward a future defined by precision, accessibility, and integrated chronic disease management.

SCOPE OF STUDY:

The report analyzes the Renal Failure Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment, Other Treatments); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Inc.
  • Akebia Therapeutics, Inc.
  • Amgen Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Calliditas Therapeutics AB
  • DaVita Inc.
  • Dialysis Clinic, Inc. (DCI)
  • Fresenius Medical Care AG & Co. KGaA
  • GSK plc
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • NIPRO Corporation
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Toray Industries, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Renal Failure Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Chronic Kidney Disease Spurs Demand for Advanced Therapies
    • Expansion of Hemodialysis Infrastructure Strengthens Business Case for Treatment Accessibility
    • Growth in Transplant Waitlists Throws the Spotlight on Alternative Renal Replacement Options
    • Adoption of Home Dialysis Technologies Expands Patient-Centered Care Models
    • Pharmaceutical Advancements in Erythropoiesis-Stimulating Agents Propel Treatment Innovation
    • Rising Prevalence of Diabetes and Hypertension Accelerates Market Penetration
    • Government Investments in Kidney Health Programs Generate Access to Early-Stage Interventions
    • Advancements in Peritoneal Dialysis Fluids Drive Adoption in Ambulatory Settings
    • Increased Availability of Wearable and Portable Dialysis Systems Enhances Treatment Flexibility
    • Telemedicine Integration Improves Monitoring and Chronic Renal Care Management
    • Expansion of Kidney Disease Screening Initiatives Supports Preventive Intervention Models
    • Strategic Collaborations Between Device Makers and Providers Foster Product Accessibility
    • Inclusion of Renal Disease in UHC Plans Strengthens Reimbursement Landscape
    • Development of Artificial Kidneys Generates Long-Term Disruption Opportunities
    • Digital Platforms for Patient Engagement Improve Therapy Compliance and Outcomes
    • Demand for Individualized Treatment Plans Drives Clinical Decision Support Tools
    • Public Awareness Campaigns Highlight Importance of Early Detection and Ongoing Care
    • Improved Cold Chain Logistics Accelerate Global Distribution of Renal Therapies
    • Clinical Trial Advancements in Combination Therapies Support Pipeline Expansion
    • Rise in Geriatric Population Sustains Need for Long-Term Renal Care Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Renal Failure Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Renal Failure Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dialysis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dialysis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Dialysis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kidney Transplantation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kidney Transplantation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Kidney Transplantation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Renal Failure Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Renal Failure Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Renal Failure Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Renal Failure Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제